We will beat
by funding novel research and innovative clinical trials utilizing precision medicine to target solid tumors in children.
Together, we will beat childhood cancer.
Childhood cancer is not yet beaten.
Children are being diagnosed with cancer every day, and several childhood cancer types have heartbreakingly low survival rates. New treatment options (within reach for families), and a deeper understanding of how these tumors work are desperately needed.
What we are doing is working. Here's how we work to beat childhood cancer:
The Beat Childhood Cancer Research Consortium (50+ children's hospitals) working to discover, design, and enroll kids on bold clinical trials.
Understanding how and why of each tumor to create personalized treatment plans.
Growing the Conversation
Amplifying the need for awareness and support.
DFMO IS NOW FDA APPROVED!
On December 13, 2023, the FDA announced the approval of DFMO! Now named "IWILFIN", it is the first pediatric neuroblastoma drug to reduce the risk of relapse for pediatric neuroblastoma patients. This less toxic, life-saving drug will now be available to every child, everywhere!
Click to read the recent article HERE